Immunological Insights Into Liver Metastasis Associated Resistance To Checkpoint Blockade Cancer Immunotherapy

被引：0
|
作者：
Lee, James [1 ]
Mehdizadeh, Sadaf [1 ]
Tsai, Katy [1 ]
Algazi, Alain [1 ]
Rosenblum, Michael [1 ]
Daud, Adil [1 ]
Bluestone, Jeffrey A. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
JOURNAL OF IMMUNOLOGY | 2018年 / 200卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
122.26
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
    Ju Yeon Lee
    Hyun Tae Lee
    Woori Shin
    Jongseok Chae
    Jaemo Choi
    Sung Hyun Kim
    Heejin Lim
    Tae Won Heo
    Kyeong Young Park
    Yeon Ji Lee
    Seong Eon Ryu
    Ji Young Son
    Jee Un Lee
    Yong-Seok Heo
    Nature Communications, 7
  • [32] Immune checkpoint blockade opens a new way to cancer immunotherapy
    Sadreddini, Sanam
    Baradaran, Behzad
    Aghebati-Maleki, Ali
    Sadreddini, Sevil
    Shanehbandi, Dariush
    Fotouhi, Ali
    Aghebati-Maleki, Leili
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (06) : 8541 - 8549
  • [33] Further Advances in Cancer immunotherapy: Going Beyond Checkpoint Blockade
    Wilkinson, Robert W.
    Leishman, Andrew J.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [34] Immune Checkpoint Blockade: The Hope for Immunotherapy as a Treatment of Lung Cancer?
    Brahmer, Julie R.
    SEMINARS IN ONCOLOGY, 2014, 41 (01) : 126 - 132
  • [35] Cancer Immunotherapy Researchers Focus on Refining Checkpoint Blockade Therapies
    Jacob, Julie A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (20): : 2117 - 2119
  • [36] A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
    Xuexiang Du
    Fei Tang
    Mingyue Liu
    Juanjuan Su
    Yan Zhang
    Wei Wu
    Martin Devenport
    Christopher A Lazarski
    Peng Zhang
    Xu Wang
    Peiying Ye
    Changyu Wang
    Eugene Hwang
    Tinghui Zhu
    Ting Xu
    Pan Zheng
    Yang Liu
    Cell Research, 2018, 28 : 416 - 432
  • [37] Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
    Lee, Ju Yeon
    Lee, Hyun Tae
    Shin, Woori
    Chae, Jongseok
    Choi, Jaemo
    Kim, Sung Hyun
    Lim, Heejin
    Heo, Tae Won
    Park, Kyeong Young
    Ryu, Seong Eon
    Son, Ji Young
    Lee, Jee Un
    Heo, Yong-Seok
    NATURE COMMUNICATIONS, 2016, 7
  • [38] A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
    Du, Xuexiang
    Tang, Fei
    Liu, Mingyue
    Su, Juanjuan
    Zhang, Yan
    Wu, Wei
    Devenport, Martin
    Lazarski, Christopher A.
    Zhang, Peng
    Wang, Xu
    Ye, Peiying
    Wang, Changyu
    Hwang, Eugene
    Zhu, Tinghui
    Xu, Ting
    Zheng, Pan
    Liu, Yang
    CELL RESEARCH, 2018, 28 (04) : 416 - 432
  • [39] Immunotherapy for the Treatment of Breast Cancer: Checkpoint Blockade, Cancer Vaccines, and Future Directions in Combination Immunotherapy
    McArthur, Heather L.
    Page, David B.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (11) : 922 - 933
  • [40] Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy
    Boyero, Laura
    Sanchez-Gastaldo, Amparo
    Alonso, Miriam
    Francisco Noguera-Ucles, Jose
    Molina-Pinelo, Sonia
    Bernabe-Caro, Reyes
    CANCERS, 2020, 12 (12) : 1 - 36
12345